Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome
Yao syndrome (YAOS) is a systemic autoinflammatory disease (SAID), formerly termed nucleotide-binding oligomerization domain-2 (NOD2)-associated autoinflammatory disease. Due to the recent identification of YAOS, the molecular mechanisms underlying its disease pathogenesis are unclear. With specific...
Main Authors: | Christine McDonald, Min Shen, Erin E. Johnson, Amrita Kabi, Qingping Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | Autoimmunity |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08916934.2018.1442442 |
Similar Items
-
Treatment of refractory Yao syndrome with canakinumab
by: Caroline J. Brailsford, MS, et al.
Published: (2022-11-01) -
Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome
by: Jingyuan Zhang, et al.
Published: (2024-02-01) -
Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine
by: Qingping Yao, et al.
Published: (2019-02-01) -
Yao syndrome: Cyclical folliculitis, fevers, and abdominal pain
by: Ilhan Esse, BA, et al.
Published: (2023-05-01) -
The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review
by: Anastasios Karamanakos, et al.
Published: (2024-01-01)